research chemical SGT-151

Buy SGT-151 Online (5f-CUMYL-PeGaCLONE) is a synthetic chemical which has already proved popular with researchers all over Europe and USA. SGT-151 is a new synthetic cannabinoid chemical that is popular in most EU countries for laboratory research. It is also known as CUMYL-PeGaCLONE. Buy top purity SGT-151 and be amongst the first scientists to study this new chemical as part of your laboratory cannabinoid research program. 5F-SGT-151 (5f-CUMYL-PeGaCLONE) is a synthetic cannabinoid which has already proved popular with researchers all over Europe and USA. 5F-SGT-151 (5f-CUMYL-PeGaCLONE) is similar in many ways to 5F-ADB, but has a much higher affinity for the CB1 receptor. Acting upon the Cannabinoid receptors, SGT-151 (AKA Cumyl-Peglacone) has similar effects if not better than any other analogous including STS-135.. SGT-151 is a relatively new cannabimimetic agent, which has already proved popular with researchers all over Europe. SGT-151 is similar in many ways to 5F-ADB, but has a much higher affinity for the CB1 receptor, at least in in-vitro studies. It is based on the typical JWH-018 4 substructure template, but is chemically (and legally) distinct as both the ring and the bridge are in the same substructure. It’s not often a new agent of such good quality is synthesized, so researchers around the world are excited to experiment on SGT-151 (Chemical name 5-pentyl-2-(1-methyl-1-phenyl-ethyl)-2,5-dihydro-pyrido[4,3-b]indol-1-one). Sometimes referred to as Cumyl-PeGlaCone, SGT-151 is a potent research cannabinoid, noted for its similarity to STS-135 – a similar cannabimimetic already trusted by countless researchers. Although only recently being synthesized, it is fast becoming a popular agent, trusted by researchers around the world. SGT-151 is legal across the EU and in Germany (yeehaaa!) where almost all other cannabinoids are illegal. Like other SGT cannabinoids, SGT-151 is a potent agonist, quickly binding with cannabinoid receptors type 1 (CB1 receptors). Unlike THC, SGT-151 is a non-selective ‘full agonist’, meaning it binds to more cannabinoid receptors, therefore it can be inferred that large amounts of dopamine would be released during experiments on live subjects. email:[email protected] skype:vivillc1